VITANOVA LIFE SCIENCES CORPORATION (VNOV)

Every figure this model derived for VNOV, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-04-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 1,597,217 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-04-30
current assets 2,430,523 AssetsCurrent 2026-04-30
current liabilities 395,781 LiabilitiesCurrent 2026-04-30
equity 2,050,780 StockholdersEquity 2026-04-30
interest expense 0 InterestExpenseNonoperating 2026-04-30
ocf 814,407 NetCashProvidedByUsedInOperatingActivities 2026-04-30
revenue 3,025,538 RevenueFromContractWithCustomerExcludingAssessedTax 2026-04-30
sbc 179,400 ShareBasedCompensation 2026-04-30

The ratios

The figures themselves rather than their scores — what somebody looking up VNOV on one particular measure came for.

RatioValue
cash operating margin6.05
current ratio6.21
current ratio reported6.14
ebit yoy-99.7
fcf margin26.92
growth cv1.37
operating margin0.12
owner earnings margin20.99
revenue growth13.65
revenue growth per share13.65
roic0.63
rule of 4013.77
sbc pct revenue5.93

What to be careful about

What this model itself distrusts about VNOV's figures. Written by the derivation as it ran, not added afterwards.